- Treprostinil, stable prostacyclin analogue, in the treatment of pulmonary arterial hypertension2006 | First Faculty of Medicine
- Current pharmacotherapeutic options for systemic sclerosis2011 | Faculty of Medicine in Hradec Králové
- Subcutaneous treprostinil for the treatment of severe non-operable chronic thromboembolic pulmonary hypertension (CTREPH): a double-blind, phase 3, randomised controlled trial2019 | Publication without faculty affiliation
- Switching to riociguat versus maintenance therapy with phosphodiesterase-5 inhibitors in patients with pulmonary arterial hypertension (REPLACE): a multicentre, open-label, randomised controlled trial2021 | First Faculty of Medicine